早产儿支气管肺发育不良的药物治疗研究进展

Research progress in drug therapy for bronchopulmonary dysplasia in preterm infants

支气管肺发育不良(BPD)是存活极早产儿最常见的远期并发症,并且可能导致肺动脉高压,增加新生儿晚期死亡率,以及神经系统发育异常。目前关于早产儿支气管肺发育不良药物治疗的有效性及利弊仍然存在争议。本文综述了BPD的药物治疗研究进展。

Bronchopulmonary dysplasia（BPD） is the most common long-term complication in surviving extremely preterm infants. This may lead to pulmonary hypertension, increase late neonatal mortality, and cause abnormal neural development. There is still controversy over the efficacy, as well as advantages and disadvantages, of drug therapy for BPD in preterm infants. This article reviews the research progress in the drug therapy for BPD.